Cannabis Science Releases Cannabinoid-Formulated Capsule Product Line in California; Initial Capsule FormulationsReleased areCBD, Indica, and Sativa

Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today the launch of their cannabinoid-formulated capsule product line. Each of the three types of caps will be available in 25mg, 50mg, and 100mg doses and will be provided in two-dose packs with more size options to be made available in the near future.

COLORADO SPRINGS, Colo., – “We are very excited to get our next line of Cannabis Science Brand Products on the market. The Capsules are important because of the popularity and ease of the delivery mechanism. The Company reps have already begun distributing to a number of dispensaries through out California.

They anticipate the Caps to be in a much larger number of dispensaries, and look forward to being able to line the shelves with a full lineup of Cannabis Science Brand,Health-Related Products. Debuting the Caps at the Emerald Cup will be very interesting for us, with this being our first actual product contest,”stated Cannabis Science Inc., President & CEO, Co-Founder, Raymond C. Dabney.

Just in time for the Emerald Cup event in Santa Rosa, California, on December 12th and 13th, 2015.Cannabis Science will be prepared to debut their new, high potency CBD, Indica, and Sativa capsules at the event.

The capsules or “caps” are expected be used for self-medicating applications ranging from pain and inflammation reduction to neurologicaltreatments. The Emerald Cup event is expected to expose Cannabis Science’s new products to a wide audience immediately, which will help the company build brand equity in this relatively new market.

– See more at: